Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01231932 : Investigating Molecular-Genetic Correlates of Fatigue Experienced by Cancer Patients Receiving Treatment
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
- INCLUSION CRITERIA:

- Clinically localized or metastatic cancer as determined by diagnostic testing such as
cytology and imaging (such as, but not limited to non-metastatic head and neck
cancer, lung cancer, breast cancer, renal cancer)

- Scheduled to receive primary cancer treatment or salvage therapy (e.g. hormone
therapy, chemotherapy plus glucocorticosteroids, immunotherapy or a combination of
cancer treatments), and the type/s of treatment is not anticipated to change during
the course of the study

- Able to provide written informed consent

- Women and men greater than or equal to18 years of age.

EXCLUSION CRITERIA:

- Progressive or unstable disease other than cancer of any body system causing
clinically significant fatigue (e.g. class IV congestive heart failure, end-stage
renal disease, stage IV chronic obstructive pulmonary disease) including patients
with systemic infections (e.g., human immunodeficiency virus [HIV], active
hepatitis); documented recent (< 5 years) history of major depression, bipolar
disease, psychosis, or alcohol/drug dependence/abuse; uncorrected hypothyroidism,
untreated anemia; and those with chronic inflammatory disease (e.g. rheumatoid
arthritis, systemic lupus erythematosus).

- Patients regularly taking antipsychotics, and anticonvulsants, since these
medications cause significant fatigue
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01231932      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740